Aethlon Medical, Inc. (AEMD) Announces Quarterly Earnings Results
Aethlon Medical, Inc. (OTCMKTS:AEMD) posted its quarterly earnings data on Thursday. The company reported ($0.29) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.15) by $0.14.
Aethlon Medical (OTCMKTS:AEMD) opened at 4.95 on Monday. Aethlon Medical has a 52-week low of $4.02 and a 52-week high of $9.09. The stock’s market capitalization is $37.77 million. The stock’s 50 day moving average price is $4.79 and its 200-day moving average price is $5.42.
About Aethlon Medical
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Stock Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related stocks with our FREE daily email newsletter.